Johnson & Johnson, headquartered in New Brunswick, New Jersey, employs 131,900 people and focuses on healthcare through its Innovative Medicine and MedTech segments. Innovative Medicine targets various therapeutic areas, while MedTech offers products for orthopedic and cardiovascular interventions.
JNJ has been in the news recently: Johnson & Johnson (JNJ) is set to announce its quarterly earnings on July 16, 2025, which investors should watch closely. Meanwhile, analysts have mixed opinions on Kenvue (KVUE) and other companies, with Evercore ISI noting positive earnings growth for some stocks and Goldman Sachs advising caution on others.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
